Option Care Health, Inc. has announced its financial results for the third quarter of 2026, revealing a revenue increase and solid profit margins. This announcement comes as the company is in the process of being acquired by Clayton, Dubilier & Rice and McKesson Corporation, which could significantly impact the home health care services industry.

For the third quarter ending September 30, 2026, Option Care reported net revenue of $1,493.5 million, representing a 4.1% increase compared to the previous year. The company also reported a GAAP net income of $57.4 million, up 10.8%, and diluted earnings per share of $0.38, an increase of 18.8%. Adjusted EBITDA for the quarter was $124.6 million, reflecting a 4.3% rise.

This filing, submitted on November 4, 2026, highlights the company's strong operational performance, which is noteworthy given the ongoing acquisition process. The press release accompanying the filing indicates that due to the pending acquisition, Option Care will not host an earnings conference call and has withdrawn its previously disclosed financial guidance.

Option Care Health, Inc. is the largest independent provider of home and alternate site infusion services in the United States. The company operates under the SIC classification of 8082, which pertains to services in the home health care sector. With a workforce of over 8,000 team members, including more than 5,000 clinicians, Option Care is dedicated to improving care standards for patients with both acute and chronic conditions across all 50 states.

The filing reveals that the acquisition by Clayton, Dubilier & Rice and McKesson Corporation is a strategic move that may reshape the competitive landscape of the home health care sector. The merger is expected to enhance the capabilities and reach of Option Care, potentially leading to improved services and operational efficiencies.

The financial results indicate a positive trajectory for Option Care, which may bolster investor confidence as the company transitions into this new phase. However, the filing does not provide specific details on the next steps regarding the acquisition process or any anticipated regulatory hurdles.

As the home health care industry evolves, competitors will need to adapt their strategies to remain competitive in light of this significant merger. The implications of this acquisition could lead to a reevaluation of market positions among other players in the sector.